Genes differentially expressed with malignant transformation and metastatic tumor progression of murine squamous cell carcinoma

Journal of Cellular Biochemistry

Volumn 67, Issue SUPPL. 28/29, 1997, Pages 90-100

  Dong, Gang ^a   Loukinova, Elena ^a   Smith, Conrad W ^a   Chen, Zhong ^a   Van Waes, Carter ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

Antigen Sp17; Cytokine KC; Differential display; Ribosomal protein L18a; Squamous cell carcinoma; Tropomyosin

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MESSENGER RNA; PROTEIN TYROSINE KINASE; RIBOSOME PROTEIN; TROPOMYOSIN; DNA FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; KERATINOCYTE; MALE; MALIGNANT TRANSFORMATION; METASTASIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SQUAMOUS CELL CARCINOMA; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CELL TRANSFORMATION; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CLONING, MOLECULAR; DNA FRAGMENTATION; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; RNA, MESSENGER;

EID: 0031401657     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1997)28/29+<90::AID-JCB10>3.0.CO;2-K     Document Type: Article

References (62)

1. Nawroz H, Van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D (1994): Allelotype of head and neck squamous cell carcinoma. Cancer Res 54:1152-1155.
2. Van Kyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf JT, Drumheller T, Tilley BC, Carey TE (1994): Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer 9:192-206.
3. Califano J, Van der Riet P, Westra W, Nawros H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D (1996): Genetic progression model for head and neck cancer: Implication for field cancerization. Cancer Res 56:2488-2492.
4. Colburn NH, Wendel E, Srinivas L (1982): Responses of preneoplastic epidermal cells to tumor promoters and growth factors : Use of promoter-resistant variants for mechanism study. J Cell Biochem 18:261-270.
5. Yuspa SH (1994): The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis.Thirty-third GHA Clowes Memorial Award Lecture. Cancer Res 54:1178-1189.
6. Brown K, Balmain A (1995): Transgenic mice and squamous multistage skin carcinogenesis. Cancer Metastasis Rev 14:113-124.
7. Chen Z, Smith CW, Kiel D, Van Waes C (1997): Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction. Clin Exp Metastasis 15:527-537.
8. Yuspa SH, Hawley-Nelson P, Koehler B, Stanley JR (1980): A survey of transformation markers in differentiating epidermal cell lines. Cancer Res 40:4694-4703.
9. Chen Z, Rosten SI, Lord EM, Gaspari AA (1993): Murine PAM 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms. Regional Immunol 5:285-292.
10. Liang P, Pardee AB (1992): Differential display of Eucaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-971.
11. Sambrook J, Fritsch EF, Maniatis T (1989): "Molecular Cloning - A Laboratory Manual." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
12. Van Waes C, Mi-Surh D, Chen Z, Kirby M, Rhim JS, Brager R, Sessions RB, Poore J, Wolf JT, Carcy TE (1995): Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res 55:5434-5444.
13. Kajiji S, Tamura RN, Quaranta V (1989): A novel integrin (αEβ4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. EMBO J 8:673-680.
14. Kennel SJ, Godfrey V, Chang LY, Lankford TK, Foot LJ, Makkinge A (1992): The beta-4 subunit of the integrin family is displayed on a restricted subset of endothelium in mice. J Cell Sci 101:145-150.
15. Roop DR, Hawley-Nelson P, Cheng CK, Yuspa SH (1983): Keratin gene expression in mouse epidermis and cultured epidermal cells. Proc Natl Acad Sci USA, 80:716-720.
16. Sudol M, Bork P, Einbond A, Kastury K, Druck T, Negrini M, Huebner K, Lehman D (1995): Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J Biol Chem 270:14733-14741.
17. Aoyama Y, Chan Y-L, Meyuhas O, Wool IG (1989): The primary structure of rat ribosomal protein L18a. FEBS Lett 247:242-246.
18. Oquendo P, Alberta J, Wen D, Graycar JL, Derynck R, Stiles CD (1989): The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platelet α-granule proteins. J Biol Chem 264:4133-4137.
19. Kong M, Richardson RT, Widgren EE, O'Rand MG (1995): Sequence and localization of the mouse sperm autoantigenic protein, Sp17. Biol Reprod 53:579-590.
20. Schleef M, Zuhlke C, School F, Jockusch H (1994): Subtractive cDNA cloning as a tool to analyze secondary effects of a muscle disease. Characterization of affected genes in the myotonic ADR mouse. Neuromusc Disord 4:205-217.
21. Lees-Miller JP, Helfman DM (1991): The molecular basis for tropomyosin isoform diversity. BioEssays, 13: 429-437.
22. Pittenger MF, Kazzaz JA, Helfman DM (1994): Functional properties of non-muscle tropomyosin isoforms. Curr Opin Cell Biol 6:96-104.
23. Hendricks M, Weintraub H (1981): Tropomyosin is decreased in transformed cells. Proc Natl Acad Sci USA 78:5633-5637.
24. Matsumura F, Lin JJ-C, Yamashiro-Matsumura S, Thomas GP, Topp WC (1983): Differential expression of tropomyosin forms in the microfilaments isolated from normal and transformed rat cultured cells. J Biol Chem 258:13954-13964.
25. Cooper HL, Feuerstein N, Noda M, Bassin RH (1985): Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes. Mol Cell Biol 5:972-983.
26. Bhattacharya B, Prasad GL, Valverius EM, Saloman DS, Cooper HL (1990): Tropomyosins of human mammary epithelial cells: Consistent defects of expression in mammary carcinoma cell lines. Cancer Res 50:2105-2112.
27. Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB (1996): Two differentially expressed genes in normal human prostate tissue and in carcinoma. Cancer Res 56:3634-3637.
28. Braverman RH, Cooper HL, Lee H-S, Prasad GL (1996): Anti-oncogenic effects of tropomyosin: Isoform specificity and importance of protein coding sequences. Oncogene 13:537-545.
29. Rastinejad F, Conboy MJ, Rando TA, Blau HM (1993): Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin. Cell 75:1107-1117.
30. Haskill S, Peace A, Morris J, Sporn SA, Anisowicz A, Lee SW, Smith T, Martin G, Ralph P, Sager R (1990): Identification of three related human GRO genes encoding cytokine functions. Proc Nalt Acad Sci USA 87:7732-7736.
31. Oppenheim JJ, Zachariae COC, Mukaida N, Mutsushima K (1991): Properties of the proinflammatory supergene "intecrine" cytokine family. Annu Rev Immunol 9:617-648.
32. Miller MD, Krangel MS (1992): Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12:17-46.33.
33. Moser B, Clark-Lewis I, Zwahlen R, Baggiolini M (1990): Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med 171:1797-1802.
34. Schroder JM, Persoon NL, Christophers E (1990): Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity. J Exp Med 171:1091-1100.
35. Richmond A (1991): The pathogenic role of growth factors in melanoma. Semin Dermatol 10:246-255.
36. Balentien E, Mufson BE, Shattuck RL, Derynck R, Richmond A (1991): Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene 6:1115-1124.
37. Schadendorf D, Moller A, Algermissen B, Worm M, Sticherling M, Czarnetzki BM (1993): IL-8 produced by human malignant cells in vitro is an essential autocrine growth factor. J Immunol 151:2667-2675.
38. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ (1994): Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 54:3242-3247.
39. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Stricter RM (1994): Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179:1409-1415.
40. Stricter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL (1995): Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukocyte Biol 57:752-762.
41. Richmond A, Balentien E, Thomas HG, Flaggs G, Barton DE, Spiess J, Bordoni R, Francke U, Derynck R (1988): Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. EMBO J 7:2025-2033.
42. Yamada S, Ikeda H, Yamazaki H, Shikishima H, Kikuchi K, Wakisawa A, Kasai N, Shimotohno K, Yoshiki T (1995): Cytokine-producing mammary carcinoma in transgenic rats carrying the pX gene of human T-lymphotropic virus type 1. Cancer Res 55:2524-2527.
43. Sudol M (1994): Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 9: 2145-2152.
44. Pawson T (1994): SH2 and SH3 domain in signal transduction. Adv Cancer Res 64:87-110.
45. Pawson T (1995): Protein modules and signaling networks. Nature 373:573-580.
46. Erpel T, Courtneidge SA (1995): Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol 7:176-182.
47. Zhao Y, Sudol M, Hanafusa H, Krueger J (1992): Increased tyrosine kinase activity of c-Src during calcium-induced keratinocyte differentiation. Proc Natl Acad Sci USA 89:8298-8302.
48. Bork P, Sudol M (1994): The WW domain: A signaling site in dystrophin? Trends Biochem Sci 19:531-533.
49. Chen HI, Sudol M (1995): The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci USA 92:7819-7823.
50. Einbond A, Sudol M (1996): Towards prediction of cognate complexes between the WW domain and proline-rich ligands. FEBS Lett 386:1-8.
51. Mager WH (1988): Control of ribosomal protein gene expression. Biochem Biophys Acta 949:1-15.
52. Chester KA, Robson L, Begent RHL, Talbot IC, Pringle JH, Primrose L, MacPherson AJS, Boxer G, Southall P, Malcolm DB (1989): Identification of a human ribosomal mRNA with increased expression in colorectal tumors. Biochem Biophys Acta 1009:297-300.
53. Barnard GF, Staniunas RJ, Steele GD, Jr, Chen LB (1991): Increased mRNA expression of ribosomal protein L18, L37, S6 in human colon carcinoma metastasized to primary hepatoma. J Cell Biol 115:1523A.
54. Pogue-Geile K, Geiser JR, Shu M, Miller C, Wool IG, Meisler AI, Pipas M (1991): Ribosomal protein genes are overexpressed in colorectal cancer: Isolation of a cDNA clone encoding the human S3 ribosomal protein. Mol Cell Biol 11:3842-3849.
55. Chiao PJ, Shin DM, Sacks PG, Hong WK, Tainsky MA (1992): Elevated expression of the ribosomal protein S2 gene in human tumors. Mol Carcinogen 5:219-231.
56. Simon HG, Risse B, Jost M, Oppenheimer S, Kari C, Rodeck U (1996): Identification of differentially expressed messenger RNAs in human melanocytes and melanoma cells. Cancer Res 56:3112-3117.
57. Monach PA, Meredith SC, Siegel CT, Schreiber H (1995): A unique tumor antigen produced by a single amino acid substitution. Immunity 2:45-59.
58. Richardson RT, Yamasaki N, O'Rand MG (1994): Sequence of a rabbit sperm zona pellucida binding protein and localization during the acrosome reaction. Dev Biol 165:688-701.
59. Greenhalgh DA, Yuspa SH (1988): Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene. Mol Carcinogen 1:134-143.
60. Domann FE, Levy JP, Finch JS, Bowden GT (1994): Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol Carcinogen 9:61-66.
61. Domann FE, Levy JP, Birrer MJ, Bowden GT (1994): Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ 5:9-16.
62. Smith CW, Chen Z, Kiel D, Van Waes C (1998): The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1α, IL-6, GM-CSF, and KC. Clin Exp Metastasis (in press).